Julie Evans

3.7k total citations
27 papers, 2.1k citations indexed

About

Julie Evans is a scholar working on Genetics, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Julie Evans has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Molecular Biology and 4 papers in Clinical Biochemistry. Recurrent topics in Julie Evans's work include Genetics and Neurodevelopmental Disorders (7 papers), Calpain Protease Function and Regulation (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). Julie Evans is often cited by papers focused on Genetics and Neurodevelopmental Disorders (7 papers), Calpain Protease Function and Regulation (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). Julie Evans collaborates with scholars based in United Kingdom, Australia and United States. Julie Evans's co-authors include Timothy M. Frayling, Hayley Archer, Angus Clarke, Andrew T. Hattersley, Sian Ellard, John Christodoulou, Lisa I.S. Allen, Helen Leonard, Maggie Shepherd and Jozef Gécz and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Julie Evans

26 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Evans United Kingdom 20 1.2k 918 466 293 290 27 2.1k
Swaroop Aradhya United States 26 1.9k 1.5× 1.2k 1.3× 126 0.3× 130 0.4× 219 0.8× 85 2.8k
Isabelle Russell‐Eggitt United Kingdom 26 1.0k 0.8× 1.1k 1.2× 233 0.5× 177 0.6× 70 0.2× 58 2.4k
Renaud Touraine France 25 633 0.5× 1.1k 1.2× 354 0.8× 36 0.1× 97 0.3× 93 2.0k
Jean‐Louis Blouin Switzerland 27 1.1k 0.9× 1.0k 1.1× 221 0.5× 107 0.4× 56 0.2× 75 2.4k
Lynn E. Pritchard United Kingdom 10 1.0k 0.8× 381 0.4× 554 1.2× 27 0.1× 308 1.1× 12 1.7k
Hammadi Ayadi Tunisia 29 673 0.5× 1.3k 1.4× 164 0.4× 140 0.5× 298 1.0× 137 2.6k
June Davies United Kingdom 14 1.3k 1.0× 770 0.8× 609 1.3× 27 0.1× 343 1.2× 18 2.1k
Salmo Raskin Brazil 28 578 0.5× 1.5k 1.6× 88 0.2× 55 0.2× 140 0.5× 147 2.8k
Ann Nordgren Sweden 29 997 0.8× 1.1k 1.2× 129 0.3× 151 0.5× 144 0.5× 134 2.6k
Victoria Mok Siu Canada 25 868 0.7× 1.3k 1.4× 108 0.2× 97 0.3× 36 0.1× 73 1.9k

Countries citing papers authored by Julie Evans

Since Specialization
Citations

This map shows the geographic impact of Julie Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Evans more than expected).

Fields of papers citing papers by Julie Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Evans. The network helps show where Julie Evans may publish in the future.

Co-authorship network of co-authors of Julie Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Evans. A scholar is included among the top collaborators of Julie Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Evans. Julie Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagnamenta, Alistair T., Jing Yu, Julie Evans, et al.. (2022). Conclusion of diagnostic odysseys due to inversions disrupting GLI3 and FBN1. Journal of Medical Genetics. 60(5). 505–510. 9 indexed citations
2.
Uusimaa, Johanna, Vasantha Gowda, Conrad Smith, et al.. (2013). Prospective study of POLG mutations presenting in children with intractable epilepsy: Prevalence and clinical features. Epilepsia. 54(6). 1002–1011. 34 indexed citations
3.
Pitceathly, Robert D. S., Susan E Tomlinson, Iain P. Hargreaves, et al.. (2012). Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations. Journal of Neurology Neurosurgery & Psychiatry. 84(1). 107–110. 13 indexed citations
4.
Archer, Hayley, Julie Evans, David Millar, et al.. (2006). NTNG1 mutations are a rare cause of Rett syndrome. American Journal of Medical Genetics Part A. 140A(7). 691–694. 38 indexed citations
5.
Archer, Hayley, Julie Evans, Stuart W. Edwards, et al.. (2006). CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. Journal of Medical Genetics. 43(9). 729–734. 149 indexed citations
6.
Allen, Michael H., Colin Veal, Julie Evans, et al.. (2005). The Major Psoriasis Susceptibility Locus PSORS1 Is not a Risk Factor for Late-Onset Psoriasis. Journal of Investigative Dermatology. 124(1). 103–106. 77 indexed citations
7.
Kerr, Alison, Hayley Archer, Julie Evans, R.J. Prescott, & Frances Gibbon. (2005). People withMECP2mutation‐positive Rett disorder who converse. Journal of Intellectual Disability Research. 50(5). 386–394. 34 indexed citations
8.
Evans, Julie, Hayley Archer, James Colley, et al.. (2005). Early onset seizures and Rett-like features associated with mutations in CDKL5. European Journal of Human Genetics. 13(10). 1113–1120. 135 indexed citations
9.
Evans, Julie, Hayley Archer, Sharon D. Whatley, et al.. (2004). Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. European Journal of Human Genetics. 13(1). 124–126. 29 indexed citations
10.
Weaving, Linda S., John Christodoulou, Sarah Williamson, et al.. (2004). Mutations of CDKL5 Cause a Severe Neurodevelopmental Disorder with Infantile Spasms and Mental Retardation. The American Journal of Human Genetics. 75(6). 1079–1093. 375 indexed citations
11.
Asumalahti, Kati, Mahreen Ameen, Sari Suomela, et al.. (2003). Genetic Analysis of PSORS1 Distinguishes Guttate Psoriasis and Palmoplantar Pustulosis. Journal of Investigative Dermatology. 120(4). 627–632. 156 indexed citations
12.
Ferguson, Stewart C., Ian J. Deary, Julie Evans, et al.. (2003). Apolipoprotein-E Influences Aspects of Intellectual Ability in Type 1 Diabetes. Diabetes. 52(1). 145–148. 18 indexed citations
13.
Haddad, Lema, Julie Evans, Neda Gharani, et al.. (2002). Variation within the Type 2 Diabetes Susceptibility Gene Calpain-10 and Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2606–2610. 60 indexed citations
14.
Veal, Colin, Francesca Capon, Michael H. Allen, et al.. (2002). Family-Based Analysis Using a Dense Single-Nucleotide Polymorphism–Based Map Defines Genetic Variation at PSORS1, the Major Psoriasis-Susceptibility Locus. The American Journal of Human Genetics. 71(3). 554–564. 117 indexed citations
15.
Lynn, Stephen, Julie Evans, Chris White, et al.. (2002). Variation in the Calpain-10 Gene Affects Blood Glucose Levels in the British Population. Diabetes. 51(1). 247–250. 67 indexed citations
16.
Frayling, Timothy M., Julie Evans, M. Bulman, et al.. (2001). beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.. Diabetes. 50(suppl_1). S94–S94. 202 indexed citations
17.
Evans, Julie, Timothy M. Frayling, Sian Ellard, & Nick Gutowski. (2000). Confirmation of linkage of Duane's syndrome and refinement of the disease locus to an 8.8-cM interval on chromosome 2q31. Human Genetics. 106(6). 636–638. 10 indexed citations
18.
Evans, Julie, Timothy M. Frayling, Sian Ellard, & Nick Gutowski. (2000). Confirmation of linkage of Duane's syndrome and refinement of the disease locus to an 8.8-cM interval on chromosome 2q31. Human Genetics. 106(6). 636–638. 38 indexed citations
19.
Macfarlane, Wendy M., Timothy M. Frayling, Sian Ellard, et al.. (1999). Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. Journal of Clinical Investigation. 104(9). R33–R39. 201 indexed citations
20.
Evans, Julie, et al.. (1971). Radiation Therapy of Hodgkin??s Disease in Children. Investigative Radiology. 6(5). 345–345. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026